UF Medicine Research Shows the Role of Diet in Developing Liver Inflammation
UF researcher Matthew Merritt has published research describing a novel method for detecting metabolic dysfunction-associated steatotic liver disease (MASLD) in the journal Cell Reports Medicine.
Islam Named Yangbin Wang Endowed Rising Star Professor
UF researcher Md Jahidul Islam, an ECE Assistant Professor, has been named the Yangbin Wang Rising Star Professor in recognition of his cutting-edge research and impactful student mentoring.
New Study Shows Shoplifting Is Up 93% Since Before the COVID-19 Pandemic
UF startup LPRC conducted a study to examine how theft and violence have evolved since before COVID-19. The study revealed a significant increase in both the average number of shoplifting incidents and the dollars lost due to shoplifting.
Tech Tuesday: University of Florida Student Organization Demonstrate the Potential of Solar Energy Though Solar-Powered Cars
In this week’s Tech Tuesday, UF Innovate’s host Bethany Gaffey introduces Isabella Lucarelli, the vice president of the UF student organization Solar Gators.
Runners Who Wear These Shoes Are More Likely To Get Injured
UF researchers found that runners wearing thick-heeled sneakers were more likely to sustain injuries compared to those wearing flatter shoes.
AI-Powered Avatars Transform Training for Nurse Practitioners and Dentists
UF researcher Michael Bumbach has developed an AI-powered simulation program that uses avatars, virtual reality, and real-time feedback to help nursing and dental professionals.
Portage Biotech Announces Letter of Intent With Immunova for an Option To Acquire iOx Therapeutics, Ltd
UF startup Immunova, LLC, a private Connecticut-based biotechnology company, has entered into a Letter of Intent with Portage Biotech, Inc. to advance its novel immuno-oncology therapies for cancer treatment.
RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine
UF startup RTI Surgical unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.
Clinician Training Program Leads to Better Outcomes for Patients With Diabetes
UF researchers find that a tele-education program for health care providers who treat people with diabetes resulted in significant improvements in patient outcomes.
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced dosing has been completed in Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).